• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany , Eysins, Switzerland

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 1 - 2 of 2

  • Page:
  • 1

Efficacy and Safety of the Bruton’s Tyrosine Kinase Inhibitor Evobrutinib for Relapsing Multiple Sclerosis Over 3.5 Years of Treatment: An Ongoing Phase II Open-Label Extension

Author:Montalban, Xavier   Wolinsky, Jerry S.   Arnold, Douglas L.   Weber, Martin S.   Piasecka-Stryczynska, Karolina   Tomic, Davorka   Seitzinger, Andrea   Guehring, Hans   

Session Name:S16: MS Clinical Trials and Therapeutics  

Topic:MS and Inflammatory Disease  

Program Number:S16.008  

Author Institution:Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d'Hebron, Barcelona, Spain  McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX  NeuroRx Research, and Montreal Neurological Institute, Montreal, QC, Canada  Institute of Neuropathology and the Department of Neurology, University Medical Center, University of Göttingen, Göttingen, Germany  Poznan University of Medical Sciences, Poznan, Poland  Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany , Eysins, Switzerland  the healthcare business of Merck KGaA, Darmstadt, Germany, Darmstadt, Germany  

  • View Abstract
  • View Disclosure

Immune Response Following COVID-19 Vaccination (mRNA or Non-mRNA) in Patients with Relapsing Multiple Sclerosis Treated with the Bruton’s Tyrosine Kinase Inhibitor Evobrutinib: An Update

Author:Bar-Or, Amit   Cross, Anne H.   Cunningham, Anthony   Hyvert, Yann   Seitzinger, Andrea   Drouin, Elise E.   Alexandri, Nektaria   Tomic, Davorka   Montalban, Xavier   

Session Name:P2: MS Immunology and Basic Science  

Topic:MS and Inflammatory Disease  

Program Number:P2.017  

Author Institution:Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA  Washington University School of Medicine, St. Louis, MO  The Westmead Institute for Medical Research, The University of Sydney, Westmead, Australia  the healthcare business of Merck KGaA, Darmstadt, Germany, Darmstadt, Germany  EMD Serono, Billerica, MA  Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany , Eysins, Switzerland  Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d’Hebron, Barcelona, Spain  

  • View Abstract
  • View Disclosure

Displaying 1 - 2 of 2

  • Page:
  • 1

© 2015 Mira Smart Conference | http://www.mirasmart.com